Effects of Docetaxel Combined with Icotinib on Serum Tumor Markers and Quality of Life of Patients with Advanced Non-Small Cell Lung Cancer

BACKGROUND: To investigate the effects of docetaxel combined with icotinib on tumor markers in serum and quality of life of patients with advanced non-small cell lung cancer (NSCLC). METHODS: Overall, 121 patients with advanced NSCLC, admitted to the Third Affiliated Hospital of Shandong First Medic...

Descripción completa

Detalles Bibliográficos
Autores principales: LIN, Huawei, CHANG, Jing, LI, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719661/
https://www.ncbi.nlm.nih.gov/pubmed/33346209
http://dx.doi.org/10.18502/ijph.v49i10.4691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719661/
https://www.ncbi.nlm.nih.gov/pubmed/33346209
http://dx.doi.org/10.18502/ijph.v49i10.4691

Ejemplares similares